Back to Search
Start Over
The Need to Define Treatment Goals for Protein-Losing Enteropathy in Fontan Care and Research
- Source :
- Journal of the American College of Cardiology, 70(20), 2602-2603. Elsevier Inc., Journal of the American College of Cardiology, 70, 2602-2603, Journal of the American College of Cardiology, 70, 20, pp. 2602-2603
- Publication Year :
- 2017
-
Abstract
- We read with interest the recent paper by Itkin et al. [(1)][1]. The authors are to be commended for their effort. However, the results should be viewed in the context of specific limitations. First, the serum albumin level is frequently being used as a surrogate endpoint in Fontan patients with
- Subjects :
- medicine.medical_specialty
business.industry
Surrogate endpoint
medicine.medical_treatment
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
Protein losing enteropathy
MEDLINE
Context (language use)
Treatment goals
030204 cardiovascular system & hematology
medicine.disease
Gastroenterology
Fontan procedure
03 medical and health sciences
0302 clinical medicine
Serum albumin level
Internal medicine
medicine
030212 general & internal medicine
Cardiology and Cardiovascular Medicine
Intensive care medicine
business
Subjects
Details
- ISSN :
- 07351097
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology, 70(20), 2602-2603. Elsevier Inc., Journal of the American College of Cardiology, 70, 2602-2603, Journal of the American College of Cardiology, 70, 20, pp. 2602-2603
- Accession number :
- edsair.doi.dedup.....a27f471236cb31eea53f3defb6e7f05e